|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/20 | (2006.01) |
| A61K 31/437 | (2006.01) | ||
| A61P 1/04 | (2006.01) |
| (11) | Number of the document | 4054537 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20801237.7 |
| Date of filing the European patent application | 2020-11-04 | |
| (97) | Date of publication of the European application | 2022-09-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-06-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2020/080877 |
| Date | 2020-11-04 |
| (87) | Number | WO 2021/089580 |
| Date | 2021-05-14 |
| (30) | Number | Date | Country code |
| 1951255 | 2019-11-04 | SE |
| (72) |
ANDERSSON, Kjell , SE
SPRINGFELTER, Mattias , SE
YOUSEF, Gabriella , SE
|
| (73) |
Cinclus Pharma Holding AB (publ) ,
Kungsbron 1, Level 3, Elevator G, 111 22 Stockholm,
SE
|
| (54) | ORAL FORMULATION OF X842 |
| ORAL FORMULATION OF X842 |